1 |
Sartori SB, Maurer V, Murphy C, Schmuckermair C, Muigg P, Neumann ID, Whittle N, Singewald N. Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches. Int J Neuropsychopharmacol 2016;19:pyv128. [PMID: 26625894 DOI: 10.1093/ijnp/pyv128] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
|
2 |
Bright FM, Vink R, Byard RW. The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS). Neuropeptides 2018;70:1-8. [PMID: 29908886 DOI: 10.1016/j.npep.2018.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Reinscheid RK, Ruzza C. Pharmacology, Physiology and Genetics of the Neuropeptide S System. Pharmaceuticals (Basel) 2021;14:401. [PMID: 33922620 DOI: 10.3390/ph14050401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Thomasson J, Canini F, Poly-Thomasson B, Trousselard M, Granon S, Chauveau F. Neuropeptide S overcomes short term memory deficit induced by sleep restriction by increasing prefrontal cortex activity. Eur Neuropsychopharmacol 2017;27:1308-18. [PMID: 28941995 DOI: 10.1016/j.euroneuro.2017.08.431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
5 |
Kushikata T, Hirota K, Saito J, Takekawa D. Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep. Pharmaceuticals (Basel) 2021;14:483. [PMID: 34069327 DOI: 10.3390/ph14050483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Liu X, Si W, Garau C, Jüngling K, Pape HC, Schulz S, Reinscheid RK. Neuropeptide S precursor knockout mice display memory and arousal deficits. Eur J Neurosci 2017;46:1689-700. [PMID: 28548278 DOI: 10.1111/ejn.13613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
|
7 |
Chauveau F, Claverie D, Lardant E, Varin C, Hardy E, Walter A, Canini F, Rouach N, Rancillac A. Neuropeptide S promotes wakefulness through the inhibition of sleep-promoting ventrolateral preoptic nucleus neurons. Sleep 2020;43:zsz189. [PMID: 31403694 DOI: 10.1093/sleep/zsz189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
8 |
Markiewicz-Gospodarek A, Kuszta P, Baj J, Dobrowolska B, Markiewicz R. Can Neuropeptide S Be an Indicator for Assessing Anxiety in Psychiatric Disorders? Front Public Health 2022;10:872430. [PMID: 35558538 DOI: 10.3389/fpubh.2022.872430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
9 |
Sandor K, Krishnan S, Agalave NM, Krock E, Salcido JV, Fernandez-zafra T, Khoonsari PE, Svensson CI, Kultima K. Spinal injection of newly identified cerebellin-1 and cerebellin-2 peptides induce mechanical hypersensitivity in mice. Neuropeptides 2018;69:53-9. [DOI: 10.1016/j.npep.2018.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
10 |
Holanda VAD, Oliveira MC, Souza LS, Lobão-Soares B, André E, Da Silva Junior ED, Guerrini R, Calo G, Ruzza C, Gavioli EC. Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test. Eur J Pharmacol 2019;859:172557. [PMID: 31326375 DOI: 10.1016/j.ejphar.2019.172557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
11 |
Grund T, Neumann ID. Brain neuropeptide S: via GPCR activation to a powerful neuromodulator of socio-emotional behaviors. Cell Tissue Res 2019;375:123-32. [PMID: 30112573 DOI: 10.1007/s00441-018-2902-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
12 |
Si W, Liu X, Pape HC, Reinscheid RK. Neuropeptide S-Mediated Modulation of Prepulse Inhibition Depends on Age, Gender, Stimulus-Timing, and Attention. Pharmaceuticals (Basel) 2021;14:489. [PMID: 34065431 DOI: 10.3390/ph14050489] [Reference Citation Analysis]
|
13 |
Garau C, Liu X, Calo G, Schulz S, Reinscheid RK. Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus. Neuroscience 2022;496:83-95. [PMID: 35710064 DOI: 10.1016/j.neuroscience.2022.06.013] [Reference Citation Analysis]
|
14 |
Tillmann S, Skibdal HE, Christiansen SH, Gøtzsche CR, Hassan M, Mathé AA, Wegener G, Woldbye DPD. Sustained overexpression of neuropeptide S in the amygdala reduces anxiety-like behavior in rats. Behav Brain Res 2019;367:28-34. [PMID: 30914309 DOI: 10.1016/j.bbr.2019.03.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|